US small caps are historically cheap relative to large caps US small caps are historically cheap relative to large caps US small caps are historically cheap relative to large caps

US small caps are historically cheap relative to large caps

Equities 7 minutes to read
Peter Garnry

Head of Equity Strategy

Summary:  US small caps have since 2006 traded at an average valuation premium of around 35% to the S&P 500 but recently since premium has completely disappeared and small caps are now historically cheap relative to large cap stocks. The question is therefore naturally whether investors should look at small caps despite a challenging environment for equities as interest rates continue to go higher. We take a look at the different arguments for and against US small caps despite their apparent attractiveness.

Small caps have mostly traded at a premium

The pandemic and the subsequent interest rate shock have caused two seismic shifts in the relative equity valuation between US small caps (Russell 2000 Index) and large caps (S&P 500 Index). During the pandemic small caps rose to three standard deviation premium relative to the historical relationship in relative valuation. Subsequently as society came out of the pandemic and the last year’s interest rate shock the relative valuation has collapsed to historical lows. If history since 2006 is a strong gravitational force in the relative valuation US small caps indeed look cheap.

Most of the assessment that the long tail of US publicly listed companies is cheap hinges on the relative argument. In absolute terms US small caps have now the same EV/EBITDA multiple as large cap stocks and historically small caps have traded at a 35% premium to S&P 500 since 2006. The justification for a small cap valuation premium could be placed on the small cap risk premium (stating that small caps outperform large caps over time), but more recent evidence is putting doubt on this so called effect. If small caps provided higher growth rates it could be justified, but if the post pandemic period is removed from the data small caps are not growing operating income (EBITDA) faster than S&P 500. So why pay a premium for the same growth, less liquidity and more volatility?

One argument is that small caps are more dominated by retail investors that are not engaged in deep thinking over risk premium, growth rates and valuation, but merely taps into this universe because of its many interesting companies and maybe the old time narrative about small beats large. The argument for buying small caps rests mostly on small caps growing faster than large caps or that the historical valuation premium will be restored. One major risk in small caps is that smaller companies tend to do worse during economic slowdowns or outright recessions.


The Saxo Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (
- Full disclaimer (

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo or its affiliates.

Saxo Capital Markets HK Limited
19th Floor
Shanghai Commercial Bank Tower
12 Queen’s Road Central
Hong Kong

Contact Saxo

Select region

Hong Kong S.A.R
Hong Kong S.A.R

Saxo Capital Markets HK Limited (“Saxo”) is a company authorised and regulated by the Securities and Futures Commission of Hong Kong. Saxo holds a Type 1 Regulated Activity (Dealing in Securities); Type 2 Regulated Activity (Dealing in Futures Contract); Type 3 Regulated Activity (Leveraged Foreign Exchange Trading); Type 4 Regulated Activity (Advising on Securities) and Type 9 Regulated Activity (Asset Management) licenses (CE No. AVD061). Registered address: 19th Floor, Shanghai Commercial Bank Tower, 12 Queen’s Road Central, Hong Kong.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products may result in your losses exceeding your initial deposits. Saxo does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo does not take into account an individual’s needs, objectives or financial situation. Please click here to view the relevant risk disclosure statements.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit

The information or the products and services referred to on this site may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and services offered on this website are not directed at, or intended for distribution to or use by, any person or entity residing in the United States and Japan. Please click here to view our full disclaimer.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc. Android is a trademark of Google Inc.